We found that the expression of the immunoproteasome catalytic subunit, large multifunctional protease 2 (LMP2), was significantly upregulated in peripheral blood mononuclear cells of active ITP patients compared to those of healthy controls. This evidence concerns the gene PSMB9 and autoimmune thrombocytopenic purpura.